Vera Therapeutics, Inc. (VERA)
42.24
-1.21
(-2.78%)
USD |
NASDAQ |
Apr 16, 16:00
42.22
-0.02
(-0.05%)
After-Hours: 20:00
Vera Therapeutics Research and Development Expense (Quarterly) : 59.18M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 74.38M |
| Syndax Pharmaceuticals, Inc. | 78.64M |
| United Therapeutics Corp. | 139.50M |
| Cytokinetics, Inc. | 101.54M |
| Insmed, Inc. | 254.91M |